Increasing cases of Orbital Mucormycosis in recent years

Abstract

Mucormycosis is a uncommon but aggressive and lethal fungal infection, which can rapidly spread especially in immunosuppressed patients. In recent years, there has been a serious increase in the number of orbital mucormycosis cases and publications. Mucormycosis prevalence in India is approximately 70 times more than the prevalence in developed countries. Diabetes mellitus, immunosuppression and trauma are major risk factors. Recently, COVİD-19 disease is common. COVID-19 infection and its treatment lead to immunosuppression, this has made patients vulnerable to secondary infections, including mucormycosis. Ophthalmologists should be aware of the possible vision threatening complications.

Keywords

• mucormycosis
• covid19
• pandemic
• ocular infection

References

1. Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523.
2. Dadhich A, Nilesh K, Patil R, Saluja H. Unusual presentation of mucormycosis mimicking a localised sino-orbital pathology. BMJ Case Rep. 2021;14(1).
3. Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69(4):1002-4.
4. Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2021;10(4)
5. Mtibaa L, Halwani C, Tbini M, et al. Successful treatment of rhino-facial mucormycosis in a diabetic patient. Med Mycol Case Rep. 2020;27:64-7.